The induction of cyclooxygenase-2 by 17β-estradiol in endothelial cells is mediated through protein kinase C

Inflammation Research

Volumn 49, Issue 9, 2000, Pages 460-465

  Akarasereenont, P ^a   Techatraisak, K ^a   Thaworn, A ^a   Chotewuttakorn, S ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

COX 2; Endothelium; Estrogen; PGs

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; CYCLOOXYGENASE 2; ESTRADIOL; PROTEIN KINASE C; STAUROSPORINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROSTAGLANDIN SYNTHESIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

6-KETOPROSTAGLANDIN F1 ALPHA; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; EPOPROSTENOL; ESTRADIOL; HUMAN; ISOENZYMES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; PROTEIN KINASE C; SUPPORT, NON-U.S. GOV'T;

EID: 0033802870     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050617     Document Type: Article

References (52)

1. Sex, plasma lipoproteins, and atherosclerosis: Prevailing assumptions and outstanding questions
2. Vascular aspects of estrogen
3. Estrogen and the blood vessel wall
4. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture
5. Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats
6. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit
7. Induction of calcium-dependent nitric oxide synthases by sex hormones
8. Expression of constitutive NO synthase in cultured endothelial cells is enhanced by 17β-estradiol
9. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells
10. Estrogen antagonises endothelin-1 vasoconstriction in rabbit basilar artery
11. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1
12. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta
13. Systemic and uterine responses to chronic infusion of 17β-estradiol
14. The mode of action of anti-inflammatory drugs
15. Prostaglandin endoperoxide synthase: Structure and catalysis
16. Selectivity of nonsteriodal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
17. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide
18. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
19. Cyclooxygenase is an immediateearly gene induced by interleukin-1 in human endothelial cells
20. Cytokines mediate the induction of cyclooxygenase-2 by activating tyrosine kinase in bovine aortic endothelial cells stimulated by bacterial lipopolysaccharide
21. Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages
22. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria
23. Involvement of tyrosine kinase in the induction of cyclooxygenase and nitric oxide synthase by endotoxin in cultured cells
24. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
25. Human umbilical vessels and cultured umbilical vein endothelial and smooth muscle cells lack detectable protein and mRNA encoding estrogen receptors
26. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
27. 2 alpha secretion in cultured endometrial cells
28. Induction of cyclooxygenase type-2 (COX-2) in rat endometrum at the peak of serum estradiol during the estrus cycle
29. Regulation of prostaglandin endoperoxide H synthase 1 and 2 by estradiol and progesterone in nonpregnant ovine myometrium and endometrium in vivo
30. Expression of cyclooxygenase-1 and 2 in ovine endometrium during the estrous cycle and early pregnancy
31. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin-1α, tumor necrosis factor-α, glucocorticoids and 17β-estradiol
32. Regulation of cyclooxygenase-2 and prostaglandin F synthase gene expression by steroid hormones and interferon in bovine endometrial cells
33. Developmental expression of the cyclooxygenase-1 and cyclooxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids
34. Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium
35. 2 release
36. The protective effects of estrogen on the cardiovascular system
37. The differential effects of oestrogens and progestins on vascular tone
38. Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function
39. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
40. Corcoran Memorial Lecture. Hormones and vasoprotection
41. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
42. Hormone replacement therapy: Cardiovascular benefits for aging women
43. Molecular mechanisms of estrogen carcinogenesis
44. Role and regulation of cyclooxygenase-2 during inflammation
45. Role of cyclooxygenase-1 and 2 in health and disease
46. Cyclooxygenase-2 expression in human esophageal carcinoma
47. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma
48. Expression of cyclooxygenase-2 in human lung carcinoma
49. Role of cyclooxygenase-2 in acute spinal cord injury
50. Cyclooxygenase in biology and disease
51. Injury-coupled induction of endothelial eNOS and COX-2 genes: A paradigm for thromboresistant gene therapy
52. Cyclooxygenase-1 and 2